- Supported exchanges /
- NSE /
- MARKSANS.NSE
Marksans Pharma Limited (MARKSANS NSE) stock market data APIs
Marksans Pharma Limited, together with its subsidiaries, engages in the research, manufacturing, marketing, and sale of pharmaceutical formulations in the United States, North America, Europe, the United Kingdom, Australia, New Zealand, and internationally. The company offers products in the pain management, upper respiratory, cardiovascular, central nervous system, anti-diabetic, gastrointestinal, analgesics, upper respiratory, ear care, skincare, anticancer, anti-ulcerative, anti-allergy, antiviral, dietary, cardiac, dermatology, antihistamines, anti-fungal, anti-viral, laxatives, and cold and cough therapeutic areas. It also produces a range of solid oral dosage forms, including tablets and hard gelatin capsules; soft gels; essential oils; ointments; and creams and liquids, as well as prescription drugs. The company provides its products to supermarkets, high street retailers, pharmacy chains, and wholesalers. Marksans Pharma Limited was incorporated in 1992 and is headquartered in Mumbai, India.
Marksans Pharma Limited Financial Data Overview
| 337.5 | |
| 318.75 | |
| - | |
| 344 | |
| 317.65 | |
| 129.7344-344 | |
| 138 532 M | |
| 40.8144 | |
| 453 M | |
| 22 680 M | |
| 0.0021 | |
| 1.665 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Marksans Pharma Limited Fundamental Data is available in our Financial Data APIs
- Net Revenue 22 680 M
- EBITDA 4 887 M
- Earnings Per Share 7.49
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Marksans Pharma Limited Earnings via APIs
- Latest Release 2024-11-12
- EPS/Forecast NaN
Get Marksans Pharma Limited End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
